ClinicalTrials.gg
CompletedNCT07071662SIEGECUpdated Mar 27, 2026

Induction of Labor in Breech Presentation

An observational study in Labor Induction at Term, Failure and Breech Presentation at Term, sponsored by Centre Hospitalier Universitaire, Amiens. Completed at 1 site in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-27.

Sponsored by Centre Hospitalier Universitaire, Amiens · Observational

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
102
Ages
18 Years and older
Sex
Female
01

Study summary

Breech presenting fœtus were generally not offered a trial labor induction and were instead directed toward a cesarean section. This approach often led to obstetric complications for both the mother and the fetus.

This study aims to offer more labor inductions to patients with a fetus in breech presentation in order to avoid the mobidity and mortality associated with systematic cesarean sections.

02

Conditions studied

  • Labor Induction at Term
  • Failure
  • Breech Presentation at Term

Browse trials for

Keywords

  • labor induction
  • failure
  • breech presentation
03

In context

Breech Presentation

41 studies on the registry are indexed under Breech Presentation; 10 are open to participants now.

This study's enrollment of 102 is below the median of 135 across 10 observational studies indexed under Breech Presentation.

Browse Breech Presentation studies →

Lead sponsor

Centre Hospitalier Universitaire, Amiens is the lead sponsor of 586 studies on the registry; 185 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

patients with a fetus in breech presentation

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 34SA
  • singleton
  • consent for vaginal delivery
  • breech presenting

Exclusion criteria

Exclusion Criteria:

  • -34SA
  • minor
  • twin pregnancy
  • refusal of vaginal delivery
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
102 participants (actual)
Patient registry
No

Groups and cohorts

  • vaginal delivery

    Other: delivery mode

  • caesarean

    Other: delivery mode

Interventions

  • Otherdelivery mode

    To observe the different modes of delivery and evaluate the characteristics of the patients as well as maternal and fetal well being in the post partum period.

06

What researchers measure

Primary outcomes

  1. number of vaginal delivery

    Time frame: day 1

  2. Number of cesarean

    Time frame: day 1

Secondary outcomes

  1. number of Endometrite

    Time frame: day 1

  2. lactates value

    Time frame: day 1

  3. Apgar value

    Time frame: day 1

  4. Number of neonatology admission

    Time frame: day 1

07

Study locations

1 site
  • CHRU Amiens
    Amiens, 80480, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07071662
Responsible party
Sponsor
First posted
Jul 17, 2025
Start date
Jun 30, 2025
Primary completion
Oct 1, 2025
Completion
Oct 1, 2025
Last update
Mar 27, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion